ABBOTT LABORATORIES — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$44.33B
Cost of Revenue
$19.32B
R&D
$2.94B
SG&A
$12.33B
D&A
$1.43B
Operating Income
$8.05B
EBITDA
$9.49B
Interest Expense
$493M
Interest Income
$308M
Other Income/Expense
$598M
Pretax Income
$8.47B
Tax Provision
$1.94B
Net Income
$6.52B
Operating Margin
18.2%
Net Margin
14.7%
Effective Tax Rate
22.9%
Deferred Tax Assets
$9.83B
Deferred Tax Liabilities
$489M
DTA Valuation Allowance
$1.77B
ETR (Continuing Operations)
22.9%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
0.3%
ETR Foreign Differential (pp)
-1.8%
Operating Lease Cost
$391M
Revenue YoY Variation
5.7%
Income YoY Variation
18.0%